16-30 of 49
H. James Ford, MD
Martha Kingman, DNP, FNP-C
Jean M. Elwing, MD
Hilary M. DuBrock, MD
How Do Patient Experiences and PAH Perspectives Vary Across Regions and Cultures Worldwide?
MinuteCE®How Do Patient Experiences and PAH Perspectives Vary Across Regions and Cultures Worldwide?
H. James Ford, MD
PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
MinuteCE®PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
H. James Ford, MD
What Challenges and Triumphs Do Patients Face While Living With PAH?
MinuteCE®What Challenges and Triumphs Do Patients Face While Living With PAH?
H. James Ford, MD
Managing Travel With PAH: Logistics, Medications, Oxygen, and Emergency Preparedness
MinuteCE®Managing Travel With PAH: Logistics, Medications, Oxygen, and Emergency Preparedness
Martha Kingman, DNP, FNP-C
PH Management in Unique Patients and Conditions
CME/CE Broadcast ReplayPH Management in Unique Patients and Conditions
Martha Kingman, DNP, FNP-C
Ioana Preston, MD
Jean M. Elwing, MD
- advertisement
New and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
CME/CE Broadcast ReplayNew and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
Vallerie V. McLaughlin, MD
Ioana Preston, MD
Kelly Chin, MD, MSCA
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
CME/CENon-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Robert D. Suh, MD
Lea Azour, MD
Ashwin Basavaraj, MD
The Safety of Sodium Oxybate in Treating Narcolepsy
CME/CEThe Safety of Sodium Oxybate in Treating Narcolepsy
Clete A. Kushida, MD, PhD
Sally Ibrahim, MD, FAAP
Right Heart Catheterization: Mastery of Precision Techniques
CME/CE Broadcast ReplayRight Heart Catheterization: Mastery of Precision Techniques
Richard Krasuski, MD
Vallerie V. McLaughlin, MD
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
CME/CEPatient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Jonathan Leventhal, MD
Shahnaz Singh-Kandah, NP
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
CME/CEPulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Vallerie V. McLaughlin, MD
- advertisement
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
CME/CE Broadcast ReplayPulmonary Hypertension: Comorbidities With PAH and Group 2 PH
Vallerie V. McLaughlin, MD
Thomas Cascino, MD
Bradley A. Maron, MD
Pulmonary Hypertension Management: Practice Trends and Updates
CME/CE Broadcast ReplayPulmonary Hypertension Management: Practice Trends and Updates
Vallerie V. McLaughlin, MD
Victor Moles, MD
Ioana Preston, MD
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
CME/CE Broadcast ReplayRisk Assessment in Pulmonary Hypertension: Practice Trends and Updates
Robert P. Frantz, MD, FACC
Vallerie V. McLaughlin, MD
Sonja Bartolomei, MD
